This liquid filling system was designed to fill, insert a pump, crimp, and cap containers at rates greater than 50 cpm. The difficulty of accurately placing a dip tube/pump into a small neck opening and crimping the closure onto a glass bottle is the challenge that is solved with this system.
Impax Laboratories Inc. said Friday it is now selling a generic version of the migraine drug Zomig. Impax is now selling a low-cost generic version of Zomig tablets and orally disintegrating Zomig tablets in two strengths. Zomig, or zolmitriptan, is available in tablet and nasal spray form and as...
FreezeBooster™ is a patented technique to enable controlled nucleation during the freezing step of the freeze drying cycle. A combination of the most sophisticated laboratory freeze dryer with the most powerful PC/PLC control system to enable One-Run Protocol development.
CD-3 is a new tool in the Food and Drug Administration’s fight against counterfeit products. CD-3 is a low-cost, portable tool that uses light to detect counterfeit products. CD-3 can be deployed anywhere and is helping the FDA protect consumers.
Scientists have used cloning technology to transform human skin cells into embryonic stem cells, an experiment that may revive the controversy over human cloning. These cloned cells can be used to create fresh tissue in the lab to repair damage done by various ailments.
Atlas Venture has entered into Corporate Strategic Partnership (CSP) agreements with both Amgen, through its venture capital fund, Amgen Ventures, and Novartis. The CSP agreements are in conjunction with the closing of Atlas IX in which Amgen Ventures and Novartis are new limited partners.
The World Health Organization says a yellow fever booster vaccination given 10 years after the initial shot isn't necessary. The U.N.'s global health agency said Friday that its expert group on immunization believes a single dose of vaccination is sufficient to confer lifelong immunity against the disease.
Changes in the marketplace have forced the public health community to wrestle with the idea that some tobacco products may pose less of a health risk than others, the new head of the Food and Drug Administration's tobacco control efforts told an industry group on Thursday.
Halozyme posted results from an early-stage trial that included its drug PEGPH20 as a treatment for pancreatic cancer. The regimen included PEGPH20 and the cancer drug Gemzar. Halozyme said PEGPH20 may make tumors more vulnerable to treatment by depleting their defenses and changing their metabolism.
Galapagos NV and AbbVie announced today an extension of their GLPG0634 clinical development collaboration to include Crohn's disease. Galapagos will fund and complete a Phase 2 program in Crohn's disease, which is designed to facilitate rapid progression into Phase 3.
Oramed Pharmaceuticals Inc. a developer of oral drug delivery systems, announced today that the United States Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug application(IND) for ORMD-0801, its oral insulin capsule.
High-shear mixers that can be quickly and cost-effectively customized to meet unique processing challenges. Mixing processes vary from each application but having a flexible bowl configuration offers greater efficiency and permits working volumes from 30 – 90% of full capacity.
The ChemSeal line features both single and double cartridge configurations designed for easy installation and maintenance. The ChemSeal cartridge seals can be readily removed from the agitator as a complete assembly and quickly repaired on the workbench before re-installation, saving maintenance time and effort.
The 500 Grinder Pumps feature compact, lightweight designs that combine an efficient solids reduction unit with a high performance progressing cavity pump. It offers a variety of innovative design characteristics.